Equine Metabolic Syndrome Study Guide

Overview and Clinical Importance

Equine Metabolic Syndrome (EMS) is a collection of clinical abnormalities characterized by insulin dysregulation (ID) as the core feature, with regional or generalized adiposity and predisposition to hyperinsulinemia-associated laminitis (HAL). EMS represents over 90% of all laminitis cases in the general equine population, making it the leading cause of laminitis. Understanding EMS pathophysiology, diagnosis, and management is essential for NAVLE success and clinical practice.

The condition shares similarities with human metabolic syndrome (Type 2 diabetes risk factors) but differs in that the primary clinical consequence in horses is laminitis rather than cardiovascular disease. EMS was first formally described by Johnson in 2002 and has since become one of the most important endocrine disorders in equine practice.

Pathophysiology

Insulin Dysregulation

Insulin dysregulation (ID) is the central feature of EMS and can manifest as one or more of the following: basal (resting) hyperinsulinemia, postprandial or post-challenge hyperinsulinemia, and tissue insulin resistance (hepatic and/or peripheral). Hyperinsulinemia is the most important pathophysiologic feature because it directly causes laminitis.

The enteroinsular axis plays a significant role in EMS. Oral glucose administration stimulates greater insulin secretion than IV glucose due to incretin hormones including gastric inhibitory polypeptide (GIP) and glucagon-like peptides 1 and 2 (GLP-1, GLP-2). This explains why the oral sugar test is more sensitive for detecting insulin dysregulation than basal testing.

Components of Insulin Dysregulation

Hyperinsulinemia-Associated Laminitis (HAL)

Prolonged hyperinsulinemia causes laminitis through several proposed mechanisms. The current leading theory involves stimulation of insulin-like growth factor 1 receptors (IGF-1Rs) on lamellar cells. Additional mechanisms include vasoregulatory effects (insulin normally promotes vasodilation via nitric oxide synthesis; insulin resistance may promote vasoconstriction), altered glucose metabolism in lamellar tissues, and secondary matrix metalloproteinase activation.

HAL differs histologically from sepsis-associated and supporting-limb laminitis. Characteristic findings include narrowing, stretching, and elongation of secondary epidermal lamellae with cellular proliferation, dermal leukocyte infiltration, and basement membrane damage.

Clinical Presentation

Typical Phenotype

Horses with EMS typically present with obesity (body condition score of 7 or greater out of 9) and characteristic regional adiposity. However, a lean EMS phenotype exists where horses have normal body condition but still exhibit insulin dysregulation. These horses are often described as "easy keepers" or "good doers" by owners.

Sites of Regional Fat Deposition

Laminitis Presentation

Laminitis in EMS horses is often chronic and insidious. Many horses show evidence of previous subclinical episodes at first presentation, including divergent hoof growth rings (wider at heel than toe), stretched or separated white line, and radiographic evidence of coffin bone rotation or pedal osteitis. Clinical signs include:

• Short, choppy forelimb gait ("walking on eggshells")
• Difficulty circling in either direction
• Increased or "bounding" digital pulses
• Positive hoof tester response at tip of frog
• Classic laminitic stance (leaning back onto heels to relieve forefoot pressure)
• Reluctance to walk on hard surfaces; preference for soft ground

Risk Factors and Breed Predisposition

Predisposed Breeds

EMS develops most commonly in horses between 5 and 16 years of age with no sex predilection. Certain breeds are highly predisposed, particularly those evolved or bred to survive on sparse forage ("thrifty" breeds). These animals are more efficient at utilizing calories and storing energy.

Additional Risk Factors

• Diet high in nonstructural carbohydrates (NSC): Grain, sweet feeds, lush pasture especially in spring and fall
• Physical inactivity: Decreased exercise reduces insulin sensitivity
• Genetic predisposition: Familial patterns observed; if parents were "good doers," offspring at higher risk
• Concurrent PPID: Approximately 30% of middle-aged and older horses have both conditions
• Endocrine disrupting chemicals: Emerging evidence suggests environmental exposure may contribute

Diagnosis

Diagnosis of EMS requires documentation of insulin dysregulation. Obesity and cresty neck alone are NOT sufficient for diagnosis. Conversely, absence of obesity does NOT exclude EMS. Diagnostic testing should be performed in a low-stress environment because pain, stress, and recent feeding affect insulin concentrations.

Physical Examination

A thorough physical examination should include body condition scoring (Henneke 1-9 scale), cresty neck scoring (0-5 scale), examination for regional adiposity, and careful hoof evaluation including digital pulses and hoof tester examination. Lateromedial radiographs should be obtained even in absence of clinical lameness to evaluate for subclinical laminitis.

Cresty Neck Scoring System (0-5 Scale)

Laboratory Testing

Differentiating EMS from PPID

EMS and Pituitary Pars Intermedia Dysfunction (PPID, equine Cushing's disease) share several features including laminitis predisposition and possible insulin dysregulation. Approximately 30% of horses have both conditions concurrently. Key differences help distinguish them:

Treatment and Management

EMS management requires a comprehensive, long-term approach combining dietary modification, exercise, and potentially pharmacological therapy. There is no cure for EMS; the goal is to control insulin dysregulation and prevent laminitis episodes. Owner compliance is critical for success.

Dietary Management

Diet is the cornerstone of EMS treatment. The primary goals are to restrict nonstructural carbohydrates (NSC), reduce caloric intake for weight loss if obese, and prevent postprandial hyperinsulinemia.

Dietary Recommendations

Exercise Program

Exercise significantly improves insulin sensitivity. For horses without active laminitis, aim for 30 or more minutes of trotting and cantering daily. For horses with stable, recovered laminitis, start with low-intensity exercise on soft surfaces (fast trot to canter, heart rate 110-150 bpm) for greater than 30 minutes, at least 3 times per week. Monitor carefully for lameness.

Exercise is CONTRAINDICATED in horses with active, unstable laminitis. Wait until pain is controlled and hooves are stable before initiating exercise.

Pharmacological Treatment

Medications are used when diet and exercise alone are insufficient. No drugs are currently licensed specifically for EMS in horses.

Prognosis and Monitoring

Prognosis varies based on severity of insulin dysregulation, extent of laminitic damage, and owner compliance with management protocols. Many horses respond well to dietary and exercise management. Horses that are "easy keepers" with persistently high insulin may require long-term medical therapy. EMS is a lifelong condition requiring ongoing management; there is no cure.

Monitoring Recommendations

• Recheck body condition and cresty neck scores monthly
• Repeat insulin testing every 3-6 months to assess response
• Monitor digital pulses and hoof quality regularly
• Repeat foot radiographs if signs of laminitis recur
• Screen for PPID (ACTH or TRH stimulation) when horse reaches 12-15 years

Complications

Hyperlipemia: When obese EMS horses become anorectic due to illness, excessive fat mobilization can overwhelm hepatic capacity, causing hepatic lipidosis and a dangerous metabolic spiral. Requires emergency intervention. Laminitis: May progress to coffin bone rotation, sinking, or penetration of sole in severe cases. Reproductive issues: Mares may experience infertility or irregular estrous cycles.